DUBLIN, March 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

The firm has a market cap of $10.47 million, a P/E ratio of -0.26 and a beta of 1.21. Trinity Biotech has a 12 month low of $0.48 and a 12 month high of $3.55. The stock has a 50-day moving ...

European equities traded in the US as American depositary receipts kicked off the week on a down note Monday morning, falling 0.87% to 1,321.99 on the S&P Europe Select ADR Index. From continental ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

As of 1:48:46 PM EDT. Market Open.

With Trinity International University’s Bannockburn campus up for grabs, Dallas-based Hillwood makes a move for about 80 ...

The researchers identified the structure of this machine, the mitochondrial pyruvate carrier (MPC), and 50 years since its discovery, have shown how it operates like the lock on a canal to transport ...

Shanghai-based VelaVigo has been busy. The biotech granted Avenzo Therapeutics ex-China rights to a Nectin4xTROP2 bispecific antibody-drug conjugate in November, netting up to $50 million in ...

Mural Oncology is a biotechnology company that focuses on using its protein engineering platform to develop cytokine-based immunotherapies for cancer treatment. The company aims to deliver ...

As per Vantage Market Research, the Global Hba1c Testing Device Market has been significantly growing over the years due to ...